C-GVJ1Repair Biotechnologies
cholesterol degradation, atherosclerotic plaque regression
clearingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-GVJ1
C-GVJ1C-GVJ1cholesterol degradation, atherosclerotic plaque regression
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Targeting drugs sounds simple… but in reality, it’s one of the biggest challenges in biotech. ⚡ Mourad Topors (Chief Scientific Officer, Repair Biotechnologies) explains why lipid nanoparticles mostly work in the liver and why site-specific delivery to other organs is still out of reach. 🧬 This clip dives into the science behind drug delivery, risk, and the hidden advantage of the liver’s unique structure. 🎯 👉 Watch the full podcast for more insights into the future of biotech.
A Breakthrough Story in Rare Cardiovascular Disease Join us for a live investor webinar with Repair Biotechnologies, a company advancing a first-in-class therapeutic platform initially targeting Homozygous Familial Hypercholesterolemia (HoFH), a life-threatening, ultra-rare disease with limited treatment options and significant unmet need. This exclusive event will provide an inside look at Repair’s mission, science, and near-term roadmap, highlighting why NOW is a critical moment for investors to engage with this story. Featured Speakers: 👤 Reason, CEO & Co-Founder, Repair Biotechnologies 🧬 Dr. Mourad Topors, CSO & Co-Founder, Repair Biotechnologies 🧠 Dr. Daniel Karlsberg, Scientific Advisory Board Member, Repair Biotechnologies What You’ll Learn: 🔹 What makes Repair’s science truly novel and disruptive 🔹 Why HoFH presents a unique opportunity for high-impact innovation 🔹 How Repair’s platform could unlock broader applications BEYOND RARE DISEASE, and what that market op
Mourad Topors, Repair Biotechnologies, USA, presents at the 11th Aging Research and Drug Discovery meeting: Clearance of Excess Intracellular Free Cholesterol Reverses Cardiovascular and Metabolic Disease
The longevity industry is booming right now. Millions of dollars of investment and donations are pouring into startups, research labs, and organizations that are seeking to understand and solve the problem of human aging. And this means that more and more people are joining the fight, both because of the positive impact they can make on the world, and because there’s potentially a lot of money to be made. But you don't need a background in medicine or biology for careers in longevity science. Plenty of well known people come from what might be considered non-traditional backgrounds and work in life extension. Nathan Cheng, the Program Director of the On Deck Longevity Biotech Fellowship, recently highlighted some examples of leaders and founders working on aging that came from various backgrounds. Jonah Sinick received his Ph.D. in Mathematics at the University of Illinois, where he focused on number theory and hyperbolic geometry. He was formerly head of Data Science at BioAge Labs
In this panel from Ending Age-Related Diseases 2019, Bill Cherman of Repair Biotechnologies, Dr. James Peyer of Kronos Ventures, Michael Greve of the Forever Healthy Foundation, Joe Betts Lacroix of YCombinator, Sree Kant of Life Biosciences, and Matthew Scholz of Oisin Biotechnologies discuss how to invest in rejuvenation biotechnology. The topics include the need for investment diversification, which areas are most likely to be successful in the short term, funding sources such as high-net-worth individuals, the problem of clinical trial funding, founders and equity retention, the future cost of rejuvenation treatments, wide adoption of rejuvenation, the problem of having 15-year timelines, and many other related items. HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and in
Second panel of "Biotech Investing in Longevity": Aubrey de Grey (CSO, SENS Research Foundation), Gordon Lithgow (Professor, Buck Institute for Research on Aging), Mike West (CEO, AgeX Therapeutics), in discussion with Anastasiya Giarletta. Aikora Health and Foresight Institute joined forces to organize a series of talks on biotech investment and longevity. They gathered a curated group of entrepreneurs, scientists, and investors to discuss exciting projects that seek to extend human healthspan, surveying a diversity of novel approaches, and discussing which ambitious goals are realistically within our reach. Other videos from this event here: https://www.youtube.com/playlist?list=PLH78wfbGI1x0Bpmq40HEVtYGj_CsEfHSk This event took place on 1st May 2019 in San Francisco. Speakers included: Mark Katakowski, President and CSO of Forever Labs Reason, CEO of Repair Biotechnologies Sergio Ruiz, Managing Director of the Methuselah Fund Doug Ethell, CEO of Leucadia Therapeutics Vittorio
Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gen … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board July 3, 2024 | 3 min read Twitter LinkedIn Facebook Email Print SYRACUSE, NY / ACCESSWIRE / July 3, 2024 / Repair Biotechnologies, Inc. ( https://www.repairbiotechnologies.com/ ), a biotechnology company developing first-in- … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Mourad Topors, PhD Speaking Profile | The Gazebo- Speaker Directory About Explore Events Solutions Explore Events Write Review Learning Hub Solutions Speakers by Categories Top Rated Speakers Log in Sign up Speakers by Categories Top Rated Speakers Speaker Directory Home Pharma and Healthcare Profile Contact Mourad Mourad Topors, PhD Chief Scientific Officer Repair Biotechnologies Country or State Canada Bio Current Position Degrees Past Talks Skills Bio Influential and innovative biomedical executive with experience leading and managing teams in translational medical research and drug develop … Recruiting Financial Planning Clinical Trials Drug Development Medical Writing Grant Writing Biochemistry Databases Negotiation Interpersonal Skills Presentation Skills French Vascular Biology Translational Research PK/PD Biomarker Development Grant Reviewing Networking English Problem Solving Decision-Making Teamwork [email protected] Made with ❤️ by passionate Eventiblers ! Company About Us Contact Us Eventible Write a Review Discover Top Events The Learning Hub Scorin
AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality - HealthTech HotSpot Skip to content LinkedIn X Facebook YouTube About Contact Us Editorial Guidelines Hot HealthTech News, Views and Trends Search for: Home Home Digital Health Health AI Healthcare IT Medical Imaging More HealthTech Events HIMSS 2026 HLTH 2025 RSNA 2025 SUBSCRIBE Search for: Home Home Digital Health Health AI Healthcare IT Medical Imaging More HealthTech Events HIMSS 2026 HLTH 2025 RSNA 2025 SUBSCRIBE Home Home Digital Health Health AI Healthcare IT Medica
Repair Biotechnologies’ LNP/mRNA therapy reverses atherosclerosis progression in mouse models | BioWorld BioWorld. Link to homepage. BioWorld BioWorld Science BioWorld Asia Data Snapshots Biopharma Medical technology Infographics: Dynamic digital data analysis Index insights NME Digest Special reports Infographics: Dynamic digital data analysis Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A scorecard Bioworld 2025 review BioWorld MedTech 2025 review BioWorld Science 2025 review Women's health
Scientific Advisory Board - Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Scientific Advisory Board Scientific Advisory Board The Scientific Advisory Board lends their knowledge and expertise in pursuit of our reversal of atherosclerosis and other cholesterol-driven conditions. Richard Honkanen, PhD Inventor Richard Honkanen is the inventor of the original technology o … ived several awards for his work, including V Foundation Translational Research Award, Lorenzo Cappussotti Award, and Jonathan Kraft Translational Award. Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us
Reason to present at the 6th Aging Research for Drug Discovery Forum in Basel - Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Reason to present at the 6th Aging Research for Drug Discovery Forum in Basel Reason to present at the 6th Aging Research for Drug Discovery Forum in Basel Date June 21, 2019 Written by Repair Biotechnologies Friday, June 21, 2019 – Today … North American Artificial Intelligence for Aging Research and Drug Development Award accompanied with the industry brief. Brief company video: https://www.youtube.com/watch?v=l62jlwgL3v8 . Official website: http://insilico.com About the Scheibye-Knudsen Laboratory The growing proportion of the elderly population represents an increasing socioeconomic challenge, not least because of age-associated diseases. It is therefore increasingly pertinent to find interventi
AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality NEW WHITE PAPER: Solving Atypical Protein Expression with Transposase Technology Dive in today! About Us Our Company Executive Leadership Locations Global Facilities Network Seattle Copenhagen Heidelberg Milan Chiba Our Services Offerings Mammalian Microbial pDNA Viral Vectors Cell Therapy mRNA Specialized Platforms & Programs AGCellerate™ BravoAAV™ ProntoLVV™ Proveo™ CMC Jumpstart™ Services Tech Transfer Process Development Cell Line Development Anal … s Release Cell Line Development AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance April 27, 2026 at 8:30 AM Our Mission Our Mission To work side by side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market. Links Links About Us Our Services Locations Careers Contact Us Media Kit News News Featured Blog Image AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical
Repair Biotechnologies CEO presents at 2025 BIO International Convention You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today. Please, enable javascript! Upstate Medical University The Internet connection is missing right now, but you're able to browse previously opened pages offline. Please, enable javascript. You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today. Contact Us Home About CNYBAC About CNYBAC Advisory Board Members Location Staff Contact Us Resources Resources Mentors and Startup Support Or … Startup Support Organizations Mentors and Startup Support Organizations Mentor Application Upstate Core Facilities Upstate Research Centers & Institutes Upstate Industry Research Office Upstate Medical University Service Provider Network News (current) Events Medical Device Innovation Challenge Medical Device Innovation Challenge 2026 Medical Device Innovation Challenge (MDIC) Application MDIC Graduate Milestones Client Information Client Information Current Clients Clie … stones Client Information Client Information Current Clients Client Accelerator Application Graduate Clients and MDIC Teams UBV Investment Fund Theater Event Rental Theater Event Rental Event Space Use Request Form Search Search CNY Biotech Accelerator, Upstate Medical University Website Search ... Search A NYS Certified Business Incubator A PROGRAM OF CNY Biotech Accelerator, Upstate Medical University 841 East Fayette St. Syracuse, NY 13210 Map & Directions Email Email
Repair Biotechnologies, Inc. - BIO International Convention 2026 Start your engines! BIO 2026 is June 22-25 at the San Diego Convention Center. Program announced! See the 130+ sessions in 18 focus areas. Generate Your Personal Event Schedule in Seconds! GENERATE NOW Start your engines! BIO 2026 is June 22-25 at the San Diego Convention Center. Program announced! See the 130+ sessions in 18 focus areas. Generate Your Personal Event Schedule in Seconds! GENERATE NOW June 22-25 | San Diego Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Companies Participati … g™ Spotlights Amgen Genentech Boehringer Ingelheim Lilly Sanofi Academic Campus Apply for Academic Campus Exhibition Exhibition Directory Exhibitor List Exhibition Map Networking Networking at BIO Receptions Exhibitor In-Booth Events Other Events Social Spotlight Events Affiliate Events Application List your event Special Experiences 5K and 1 Mile Course Match Day Lounge Travel Hotel Reservations Book Your Hotel Interactive Hotel Map Hotels by Amenity Hotel Guidelines Transpo
Repair Biotechnologies, Inc. - BIO International Convention 2026 Start your engines! BIO 2026 is June 22-25 at the San Diego Convention Center. Program announced! See the 130+ sessions in 18 focus areas. Generate Your Personal Event Schedule in Seconds! GENERATE NOW Start your engines! BIO 2026 is June 22-25 at the San Diego Convention Center. Program announced! See the 130+ sessions in 18 focus areas. Generate Your Personal Event Schedule in Seconds! GENERATE NOW June 22-25 | San Diego Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Companies Participati … g™ Spotlights Amgen Genentech Boehringer Ingelheim Lilly Sanofi Academic Campus Apply for Academic Campus Exhibition Exhibition Directory Exhibitor List Exhibition Map Networking Networking at BIO Receptions Exhibitor In-Booth Events Other Events Social Spotlight Events Affiliate Events Application List your event Special Experiences 5K and 1 Mile Course Match Day Lounge Travel Hotel Reservations Book Your Hotel Interactive Hotel Map Hotels by Amenity Hotel Guidelines Transpo
Ending aging: the SENS approach | In his talk, Reason of Repair Biotechnologies addressed the reasons why rejuvenation biotechnology is not proceeding as fast as it could be and discus...
Reason | Repair Biotechnologies | Interview with Sponsors - ARDD2024 - YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Working in Longevity with a Non-Traditional Background - Society & Politics - LONGECITY ....................... Google Sign in options Remember me This is not recommended for shared computers Sign in anonymously Don't add me to the active users list Privacy Policy Sign In Create Account ::: --> L onge C ity Advocacy & Research for Unlimited Lifespans .org About UserAgreement Constitution Stewards MembersList Districts Homepage Portal Forum Blogs FacebookP … September 2021 - 01:53 PM The Program Director of the On Deck Longevity Biotech Fellowship gives us some examples of leaders and founders working on aging that came from “non-traditional” backgrounds. The myth that you need a biology degree to work in the longevity industry Many people are interested in getting involved in longevity but hesitate because they think a Ph.D. or B.S. in biology is a strict requirement. Not true! Not everyone in longevity comes from th … -->  -->  --> Laura Deming Affiliation: Founder, The Longevity Fund Background: Physics, Cynthia Kenyon’s Lab. In 2011, Laura Deming, a Thiel Fellow and former protege of Cynthia Kenyon, founded the first longevity-focussed venture fund at the age of 17. Although she did some C. elegans biology work in Kenyon’s lab when she was 14, she actually went on to study physics at MIT. Laura Deming would later drop out after being awarded a Thiel Fellowship. The rest … on Twitch, has a fondness for bionumbers, first principles thinking, etc). Her fund, The Longevity Fund, invests in companies that often have an unusual aging angle. Joining the longevity industry Are you interested in doing something about aging by getting involved in longevity startups? The On Deck Longevity Biotech Fellowship is a community of founders, operators, experts, and investors all focussed on building revolutionary longevity biotech startups. We are currently ac
An Interview with Karl Pfleger – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » February 5th, 2024 An Interview with Karl Pfleger … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room | Resources | About Read our terms and conditions and privacy poli
Longevity Resources [updated Aug 13, 2021] Longevity Marketcap Newsletter Subscribe Sign in Longevity Resources [updated Aug 13, 2021] Nathan S. Cheng Aug 13, 2021 3 4 Here’s a list of longevity science and industry resources to get you started. If you have any suggestions please leave them in the comments below. Blogs / Posts Laura Deming’s Short Longevity FAQ - A > 10 min read on the basics of longevity science. Jose Luis Ricon’s Longer Longevity FAQ - A more in-depth read on the biology of aging. Hallmarks of Aging - A review (2013) of nine different proposed mechanisms of aging. Cited by e … ed by 100 Plus Capital. AGE1 Accelerator - Run by Laura Deming at The Longevity Fund. My projects: On Deck Longevity Biotech Fellowship (Program Director) - On Deck Longevity Biotech (ODLB) is a continuous community for people to come together to build, join, or invest in revolutionary longevity biotechnology startups. Longevity List - Find jobs, companies, and investors in the longevity industry. Email me if you want to add your job or company to the list. It’s free. Longevi … to get individuals and corporations to pledge at least 1% of their resources to fund longevity companies and research. LongevityBase.org - An open-source volunteer initiative to itemize every instance of modulation of biological aging in the scientific literature. Humans for Longevity - A literary art project featuring the stories and motivations behind the people working on solving the problem of aging. 4 Comments Top first Christine Peterson Aug 16, 2021 Liked by Nathan S.
Longevity activism at 82, 86, …–London Futurists – Apple Podcasts Search Home New Top Charts Search 10 January 2025 46 min Longevity activism at 82, 86, and beyond, with Kenneth Scott and Helga Sands London Futurists Play Our guests in this episode have been described as the world’s two oldest scientifically astute longevity activists. They are Kenneth Scott, aged 82, who is based in Florida, and Helga Sands, aged 86, who lives in London. David has met both of them several times at a number of longevity events, and they always impress him, not only with their vitality and good health, but also … ity and good health, but also with the level of knowledge and intelligence they apply to the question of which treatments are the best, for them personally and for others, to help keep people young and vibrant. Selected follow-ups: Waiting For God - 1990s BBC Comedy Adelle Davis, Nutritionist Roger J. Williams, Biochemist The Importance of Maintaining a Low Omega-6/Omega-3 Ratio Life Extension Magazine California Age Management Institute Fibrinogen and aging Professor Angus D … rch, Geneticist James Kirkland, Mayo Clinic Daniel Munoz-Espin, Cambridge Nobel Prize for John Gurdon and Shinya Yamanaka VSELs and S.O.N.G. laser Xtend Optimal Health Follistatin gene therapy, Minicircle Exosomes vs Stem Cells Prevent and Reverse Heart Disease - book by Caldwell Esselstyn Jr Dasatinib and Quercetin (senolytics) We reverse atherosclerosis - Repair Biotechnologies Bioreactor-Grown Mitochondria - Mitrix Nobel Winner Shinya Yamanaka: Cell Therapy Is ‘Very
How to Start a Biotech Company in the Longevity Industry – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » November 12th, 2019 How … r past industry, here you must be the business co-founder. Life science and its application to biotechnology is a vast, complex, intimidating field. Aging is its own highly specialized portion of that field. You need an understanding sufficient to identify a project to work on; you need a scientific co-founder; you need to know the investors and the movers and shakers. Where to even start? This document is a starting point. We hope that it helps. Comments The last prediction … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room 
Repair Biotechnologies, Inc. - Drug pipelines, Patents, Clinical trials - Synapse Products Data Feature Plans Request Demo Sign Up for Free Last update 13 May 2026 Repair Biotechnologies, Inc. Startups | Holding Company | 2018 | New York, United States | < 10 | www.repairbiotechnologies.com Startups | Holding Company | 2018 | New York, United States | < 10 | www.repairbiotechnologies.com Last update 13 May 2026 Overview Pipeline Deal Translational Medicine Profit Grant & Funding(NIH) Investment Financing Overview Tags Digestive System Disorders Cardiovascular Diseases Other Diseases … disease therapies." The company plans to open an Investigational New Drug (IND) application to enable continued close collaboration with the FDA at key development milestones. About Repair Biotechnologies: Repair Biotechnologies develops first-in-class therapies that break down the undruggable target of toxic free cholesterol inside cells to rapidly reduce arterial plaque in atherosclerosis and familial hypercholesterolemia, reverse liver fibrosis in metabolic disorders, and … itions of over 360K organizations with Synapse. login or view full example data Grant & Funding(NIH) Access more than 2 million grant and funding information to elevate your research journey. login or view full example data Investment Gain insights on the latest company investments from start-ups to established corporations. login or view full example data Financing Unearth financing trends to validate and advance investment opportunities. login or view full example data
Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Cholesterol Degrading Platform by Repair Biotechnologies We reverse atherosclerosis The first-in-class Cholesterol Degrading Platform (CDP) Repair Biotechnologies develops the Cholesterol Degrading Platform, a safe approach to treating medical conditions that arise due to localized accumulations of excess cholesterol. In pa
FDA Grants RDEP Eligibility for Repair Biotechnologies' mRNA Therapy for HoFH | Mourad Topors, PhD posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Conti … ire Repair Bio team! Like Reply 2 Reactions 3 Reactions LongevityTech.fund 2w Report this comment Congratulations! Like Reply 1 Reaction 2 Reactions Brenda Eap PhD 2w Report this comment Congratulations!! Like Reply 2 Reactions 3 Reactions Dr. Ashish Rajput, Ph.D. 2w Report this comment Congratulations! Great news. Like Reply 1 Reaction 2 Reactions See more comments To view or add a comment, sign in More Relevant Posts Shelli P. 3w Repo … . United Therapeutics Corporation announced that the FDA has #cleared its #IND #application to begin the EXPRESS clinical trial, evaluating #UHeart ™, a gene-edited pig heart, in patients with end-stage heart failure who have no remaining therapeutic options. This is important because: ✅ first FDA-cleared human clinical trial of a xenoheart ✅ intended to support a future Biologics License Application (BLA) ✅ a major step toward addressing the global organ shortage crisis 🚀 W … blic registration of trials and summary results, statutory 2-year first-patient deadline, and the Route B substantial modifications pathway. Combined MHRA/HRA review now averages 41 days; the Route B pilot processed applications in an average of 7 calendar days. 🔗 https://lnkd.in/ekcFZGq5 🇺🇸 FDA (CBER) — RMAT Designation: Orca Bio's Orca-Q (April 28) Orca-Q, a second-generation allogeneic T-cell immunotherapy for high-risk hematologic malignancies, becomes Orca Bio's secon … ca Bio's second RMAT (after Orca-T). Unlocks intensive FDA engagement, priority/rolling review, and accelerated approval eligibility — reinforcing allogeneic platforms as a regulatory priority. 🔗 https://lnkd.in/ewJX6k3V 🧬 EMA / CHMP — Positive Opinion: Itvisma (intrathecal onasemnogene abeparvovec) Novartis' AAV9-based intrathecal SMN1 gene re
--> Mourad Topors Medical Technology 3D Printing AI in Healthcare Assistive Technology Digital Health Digital Modeling Laboratory Automation Nanotechnology in Healthcare Precision Medicine Robotic Surgery Synthetic Biology Health Antibiotic Resistance Big Pharma Cancer Diabetes Heart Disease Mental Health Musculoskeletal System Respiratory Disease Stroke Augmentation Artificial Organs Biohacking Brain Interface Exoskeleton Nootropics Prostheses Vision Life Extension Aging Research Anti-Aging Biological Age Calorie Restriction Cryonics Ethics Fountains of Youth Gene Therapy Immortal Animals Inv … holds a PhD in Experimental Medicine from McGill University and a postdoctoral fellowship in the Department of Immunology at the University of Toronto. Visit website: https://www.repairbiotechnologies.com/executive-team/#mourad mouradtopors See also Repair Biotechnologies Biotechnology company focused on developing drugs for cholesterol and aging-related diseases Details last updated 20-Oct-2022 Mourad Topors News Reason reports back from October's Rejuvenation Sta
Repair Biotechnologies Presents REP-0003 Therapy for Atherosclerosis at AHA 2025 Home Insights Categories News Intelligence Platform About Us Contact Us Home Insights About Us News Categories Intelligence Platform Contact Us Home News News details Repair Biotechnologies’ presentation in favor of its drug ‘REP-0003’ Repair Biotechnologies showcases REP-0003, a new therapy reducing harmful cholesterol and atherosclerotic plaque, at AHA 2025. Category: Health Published Date: 14 November 2025 Share : --> Announcement Repair Biotechnologies Inc. highlighted its current presentation of preclinical d … r Partner Resources Events and Conferences Databook Key Insights Press Releases Submit Press Releases Companies CGT Intelligence Platform Access Dashboard Get a Subscription Company About Us Our Clients Our Team Contact Us Testimonials Legal Privacy Policy Return Policy Terms and Conditions ©2026 Towards Healthcare Research & Consulting. All Rights Reserved
Repair Biotechnologies Presents Preclinical Data at American Heart Association’s Scientific Sessions 2025 Showing Regression of Atherosclerotic Plaque with REP-0003 Treatment - Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Repair Biotechnologies Presents Preclinical Data at American Heart Association’s Scientific Sessions 2025 Showing Regression of Atherosclerotic Plaq … ged by the growing interest in this previously undruggable target following our award of Orphan Drug Designation by the U.S. Food and Drug Administration in May of this year for the treatment of HoFH.” The Repair Biotechnologies poster titled “Selective Degradation of Excess Free Cholesterol in the Liver by REP-0003 Regresses Atherosclerotic Plaque in Ldlr -/- Mice: A Novel Approach for HoFH”, was presented in a moderated digital poster session on November 9th by Dr. Topors.
Repair Biotechnologies Receives Orphan Drug Designation from the FDA for the Treatment of Homozygous Familial Hypercholesterolemia - Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Repair Biotechnologies Receives Orphan Drug Designation from the FDA for the Treatment of Homozygous Familial Hypercholesterolemia Repair Biotechnologies Receives Orphan Drug Designation from
Mourad Topors, PhD - Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Back to Executive Team Mourad Topors, PhD Chief Scientific Officer Mourad is the Chief Scientific Officer at Repair Biotechnologies. He has over 20 years of experience in successfully leading multidisciplinary teams in translational medical research, focusing on cardiovascular disease. Formerly, he was
Executive Team - Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Executive Team Executive Team Broad experience in management, fundraising, and the research and development of treatments for cardiometabolic disease. Reason Chief Executive Officer Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since i … holds a PhD in Experimental Medicine from McGill University and a postdoctoral fellowship in the Department of Immunology at the University of Toronto. Bobby Khan, MD, PhD Chief Medical Officer Bobby Khan is the Chief Medical Officer of Repair Biotechnologies. He is a cardiologist and clinical investigator, serving as Professor of Medicine at the University of Central Florida School of Medicine. Dr. Khan has published nearly 90 peer-reviewed articles in the areas of cardiova
--> Repair Biotechnologies Medical Technology 3D Printing AI in Healthcare Assistive Technology Digital Health Digital Modeling Laboratory Automation Nanotechnology in Healthcare Precision Medicine Robotic Surgery Synthetic Biology Health Antibiotic Resistance Big Pharma Cancer Diabetes Heart Disease Mental Health Musculoskeletal System Respiratory Disease Stroke Augmentation Artificial Organs Biohacking Brain Interface Exoskeleton Nootropics Prostheses Vision Life Extension Aging Research Anti-Aging Biological Age Calorie Restriction Cryonics Ethics Fountains of Youth Gene Therapy Immortal An
An Update on Reversal of Atherosclerosis at Repair Biotechnologies – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » April 11th, 2 … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room | Resources | About Read our terms and conditions and privacy poli
Repair Biotechnologies Closes Seed Round, Joins Grapeseed.bio Incubator – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » August 1 … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room | Resources | About Read our terms and conditions and privacy poli
Repair Biotechnologies Closes Pre-Seed Round, Joins Grapeseed.bio Incubator - Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Repair Biotechnologies Closes Pre-Seed Round, Joins Grapeseed.bio Incubator Repair Biotechnologies Closes Pre-Seed Round, Joins Grapeseed.bio Incubator Date September 15, 2018 Written by Repair Biotechnologies Repair Biotechnologies, a startup dev
--> Bill Cherman Medical Technology 3D Printing AI in Healthcare Assistive Technology Digital Health Digital Modeling Laboratory Automation Nanotechnology in Healthcare Precision Medicine Robotic Surgery Synthetic Biology Health Antibiotic Resistance Big Pharma Cancer Diabetes Heart Disease Mental Health Musculoskeletal System Respiratory Disease Stroke Augmentation Artificial Organs Biohacking Brain Interface Exoskeleton Nootropics Prostheses Vision Life Extension Aging Research Anti-Aging Biological Age Calorie Restriction Cryonics Ethics Fountains of Youth Gene Therapy Immortal Animals Inve … hnologies Mr. Bill Cherman is a Co-Founder & serves as Partner at Solar Eco Fund. Mr. Cherman is a Co-Founder and serves as Chief Executive Officer and editor-in-chief at Bay Area Times. He is a Co-Founder and serves as Chairman at Repair Biotechnologies. He is a Co-Founder and serves as Board Member at Wikiask. He was the Co-Founder and served as a Partner at Front Seat Capital, where he leads investments in biotech and blockchain. Previously, he was a consultant at McKi
An Interview with Reason of Repair Biotechnologies on Reversal of Atherosclerosis – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room | Resources | About Read our terms and conditions and privacy poli
Repair Biotechnologies, Author at Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Author: Repair Biotechnologies Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study BOSTON, M.A.–Repair Biotechnologies, Inc. announced today breakthrough results from a preclinical study of the Cholesterol Degrading Platform (CDP
Videos/Webinars Archives - quadraScope Ventures --> --> --> --> --> --> --> --> Skip links Skip to primary navigation Skip to content li > a"}'> Home Science Portfolio Team Videos LOGIN Toggle navigation Home Science Portfolio Team Videos BioChange – transforming tissue regeneration QUADSMaster December 30, 2025 Maintaining mitochondrial health – interview with Vincere Biosciences QUADSMaster January 25, 2025 Reversing cholesterol plaque – interview with Repair Bio QUADSMaster December 2, 2024 Clearing senescent cells to extend healthspan – interview with Deciduous Therapeutics QUADSMaster Aug
Full house at Biotech Investing in... - Foresight Institute Facebook Вход Публикация Foresight Institute Foresight Institute сейчас с Sarah Constantin и ещё 4 . 2 май 2019 г. · Поделился/-ась с Доступно всем Full house at Biotech Investing in Longevity last night! We're thrilled about the interest in this space: We had 2x as many applications as we could accommodate and are looking into making this a recurring event to give this community a continuous point of contact. If you'd like to attend a future meeting, sign up to our mailing list: bit.ly/foresightupdates . Thank you to our co … in sponsor, Forever Labs, Inc for making this event possible, and to Methuselah Fund, and Repair Bio for sponsoring. Thank you to our fantastic speakers for keeping this crowd strapped to their chairs for 3 hours: Mark Katakowski, President and CSO of Forever Labs Reason, CEO of Repair Biotechnologies Sergio Ruiz, Managing Director of the Methuselah Fund Doug Ethell, CEO of Leucadia Therapeutics Vittorio Sebastiano, Scientific Advisory Board Chairman of Turn Biotechnologies A
Latest advances in aging research and drug discovery | Aging Submit an Article Navigate Home Editorial Board Editorial Policies Current Volume Archive Scientific Integrity Publication Ethics Statements Interviews with Outstanding Authors Newsroom Sponsored Conferences Podcast Contact Special Collections Submit an Article Online ISSN: 1945-4589 Navigate Home Editorial Board Editorial Policies Current Volume Archive Scientific Integrity Publication Ethics Statements Interviews with Outstanding Authors Newsroom Sponsored Conferences Podcast Contact Special Collections Rapamycin Press LLC dba Impa … ific Meeting of the BSRA NOVA 2026 Recap Longevity & Aging Series 2025 EPIC Award Winner: Longevity & Aging Series Meeting Report | Volume 11, Issue 22 | pp 9971 —9981 Latest advances in aging research and drug discovery Daniela Bakula 1 Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark , Andrea Ablasser 2 Global Health Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland … NIFA. VNG is supported by NIH grants. AT is supported by the Russian Federation grant 14.W03.31.0012. TH is supported by the Deutsche Forschungsgemeinschaft (DFG) (CECAD) and the European Research Council (consolidator grant 616499). DCR is grateful for funding from the UK Dementia Research Institute (funded by the MRC, Alzheimer’s Research UK and the Alzheimer’s Society) (DCR), an anonymous donation to the Cambridge Centre for Parkinson-Plus, The Rosetrees Trust, The Tau Con … 027812), the Danish Cancer Society (#R167-A11015_001), the Independent Research Fund Denmark (#7016-00230B), the Neye Foundation and Insilico Medicine. References 1 . Bakula D , Aliper AM , Mamoshina P , Petr MA , Teklu A , Baur JA , Campisi J , Ewald CY , Georgievskaya A , Gladyshev VN , Kovalchuk O , Lamming DW , Luijsterburg MS , et al . Aging and drug discovery. Aging (Albany NY) . 2018 ; 10 : 3079 – 88 . https://doi.org/10.18632/aging.101646 [ PubMed ] 2 . Barzilai N , C … att M , Khaitovich P , Clish CB , Miller RA , Gladyshev VN . Identification and Application of Gene Expression Signatures Associated with Lifespan Extension. Cell Metab . 2019 ; 30 : 573 – 593.e8 . https://doi.org/10.1016/j.cmet.2019.06.018 [ PubMed ] 58 . Sziráki A , Tyshkovskiy A , Gladyshev VN . Global remodeling of the mouse DNA methylome dur
Repair Biotechnologies Raises a $2.15M Seed Round to Fight Age-Related Diseases – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room | Resources | About Read our terms and conditions and privacy poli
Repair Bio's novel platform – cholesterol therapy - exclusive from CEO Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search HAYA Therapeutics … viewers decided that it was too different from the current orthodoxy to merit a grant for further development. To their minds, if you are not in the mainstream, if you are not producing the next statin drug, an incremental improvement on lowering blood cholesterol, then your work is not worth it. This is why radical new directions in research, which are always needed, and always unpopular with the establishment, must usually be realized by some combination of philanthropy and
A Profile of Repair Biotechnologies, Working to End Atherosclerosis – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » February 10t … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing Innate Immune System Declining Lysosomal Function Mitochondrial DNA Damage Nuclear DNA Damage Buildup of Senescent Cells Archives and … Feed RSS Comments Feed Using the Fight Aging! Content Feeds Required Reading A Proposal to Accelerate Progress Calorie Restriction and Longevity Cryonics, the Necessary Backup Plan How to Argue for Longevity Science The Odds of Human Longevity Mutations The Need For Activism and Advocacy Nuanced Opposition to the FDA Potential Gene Therapy Targets Predicting the First Rejuvenation Therapies Self-Experiment to Fight Aging! SENS: Bringing an End to Aging Stem Cells and Regener … ht Aging!. Home | FAQ | Fund Research | Services | Investing | Therapies | Newsletter | Archives | Press Room | Resources | About Read our terms and conditions and privacy poli
Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases - Repair Biotechnologies Skip to content Our Science Our Pipeline Our Science Our Pipeline About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us About Our Company Executive Team Scientific Advisory Board Investors News Careers Contact Us Repair Biotechnologies’ Syracuse lab space Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases Date May 7
Repair Biotechnologies Announces Appointment of Noted Endocrinologist Prof. Frederick J. Raal to Scientific Advisory Board - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Busine … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Repair Biotechnologies Announces Appointment of Noted Endocrinologist Prof. Frederick J. Raal to Scientific Advisory Board October 17, 2025 | 2 min read Twitter LinkedIn Facebook Email Print SYRACUSE, NY / ACCESS Newswire / October 16, 2025 / Repair Biotechnologies, Inc. ( https://www.repairbiotechnologie … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Rejuvenation Startup Summit 2024 announces first set of speakers - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Rejuvenation Startup Summit 2024 announces first set of speakers November 8, 2023 | 5 min read Twitter LinkedIn Facebook Email Print Join the largest in-person gathering of CEOs from the worldwide Rejuvenation & Longevity biotech sector Join the largest in-person gathering of CEOs from the worldwide Rejuvenation &am … e Healthy Longevity Clinic and Managing Partner of LongevityTech.fund Brian Kennedy, Professor at the National University of Singapore Eric Verdin, CEO and president of the Buck Institute for Research on Aging Investors on stage: Jens Eckstein, Investment Partner at Hevolution Alex Colville, Co-Founder, General Partner at Age1 Jan Adams, Partner at Apollo Health Ventures Sergey Jakimov, Managing Partner at LongeVC Marc P. Bernegger, Founding Partner … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Repair Biotechnologies Granted Rare Disease Evidence Principles (RDEP) Eligibility by the FDA for REP-0003 in Homozygous Familial Hypercholesterolemia - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FD … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Repair Biotechnologies Granted Rare Disease Evidence Principles (RDEP) Eligibility by the FDA for REP-0003 in Homozygous Familial Hypercholesterolemia May 12, 2026 | 3 min read Twitter LinkedIn Facebook Email Print SYRACUSE, NY / ACCESS Newswire / May 12, 2026 / Repair Biotechnologies, Inc., a biotechnolo … disease therapies." The company plans to open an Investigational New Drug (IND) application to enable continued close collaboration with the FDA at key development milestones. About Repair Biotechnologies: Repair Biotechnologies develops first-in-class therapies that break down the undruggable target of toxic free cholesterol inside cells to rapidly reduce arterial plaque in atherosclerosis and familial hypercholesterolemia, reverse liver fibrosis in metabolic disorders, and … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy C … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Pharm Country Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models April 2, 2024 | 3 min read Twitter LinkedIn Facebook Email Print Repair Biotechnologies, Inc. announced today that its lipid nanoparticle (LNP)/messenger RNA (mRNA) therapy has rapidly reversed the progression of atherosc … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Repair Biotechnologies Receives Orphan Drug Designation From the FDA for the Treatment of Homozygous Familial Hypercholesterolemia - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deal … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Repair Biotechnologies Receives Orphan Drug Designation From the FDA for the Treatment of Homozygous Familial Hypercholesterolemia May 20, 2025 | 2 min read Twitter LinkedIn Facebook Email Print SYRACUSE, NEW YORK / ACCESS Newswire / May 19, 2025 / Repair Biotechnologies, Inc. ( https://www.repairbiotechn … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Thera … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Drug Development Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases May 7, 2019 | 2 min read Twitter LinkedIn Facebook Email Print Repair Biotechnologies, Inc. announced $2.15 million in seed venture funding, to accelerate the preclinical development of its pipel … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin